References

  1. Baek NI, Kim DS, Lee YH, Park JD, Lee CB, Kim SI. Ginsenoside Rh4, a genuine dammarane glycoside from Korean red ginseng. Planta Med 1996;62(1):86-7.
  2. Cao J, Zheng YQ, Liu TP, Feng LZ. Inhibitory effects of ginsenoside Rg1 and Rb1 on rat brain microsomal Na+,K(+)-ATPase activity. Chung Kuo Yao Li Hsueh Pao 1990;11(1):10-4.
  3. Chan TW, But PP, Cheng SW, Kwok IM, Lau FW, Xu HX. Differentiation and authentication of Panax ginseng, Panax quinquefolius, and ginseng products by using HPLC/MS [published erratum appears in Anal Chem 2000 May 15;72(10):2329]. Anal Chem 2000;72(6):1281-7.
  4. Chen YJ, Xie H, Pei YP, Xu SX, Yao XS. [Isolation and identification of the anti-tumor constituent, ginsenoside-Rh2]. Chung Yao Tung Pao 1988;13(1):40-2, 64.
  5. Chen YJ, Zhang SL, Wang ZX, Lu YJ, Xu SX, Yao XS, et al. [Isolation and elucidation of a new minor saponin from the leaves of Panax ginseng C.A. Meyer]. Yao Hsueh Hsueh Pao 1990;25(5):379-81.
  6. Cheng YJ, Su SX, Ma QF, Pei YP, Xie H, Yao XS. [Studies on new minor saponins isolated from leaves of Panax ginseng C. A. Meyer]. Yao Hsueh Hsueh Pao 1987;22(9):685-9.
  7. Chung E, Lee KY, Lee YJ, Lee YH, Lee SK. Ginsenoside Rg1 down-regulates glucocorticoid receptor and displays synergistic effects with cAMP. Steroids 1998;63(7-8):421-4.
  8. Corthout J, Naessens T, Apers S, Vlietinck AJ. Quantitative determination of ginsenosides from Panax ginseng roots and ginseng preparations by thin layer chromatography--densitometry. J Pharm Biomed Anal 1999;21(1):187-92.
  9. Cui JF, Garle M, Bjorkhem I, Eneroth P. Determination of aglycones of ginsenosides in ginseng preparations sold in Sweden and in urine samples from Swedish athletes consuming ginseng. Scand J Clin Lab Invest 1996;56(2):151-60.
  10. Cui M, Song F, Zhou Y, Liu Z, Liu S. Rapid identification of saponins in plant extracts by electrospray ionization multi-stage tandem mass spectrometry and liquid chromatography/tandem mass spectrometry [In Process Citation]. Rapid Commun Mass Spectrom 2000;14(14):1280-6.
  11. Danesi R, Figg WD, Reed E, Myers CE. Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells. Mol Pharmacol 1995;47(6):1106-11.
  12. Deng HL, Zhang JT. Anti-lipid peroxilative effect of ginsenoside Rb1 and Rg1. Chin Med J (Engl) 1991;104(5):395-8.
  13. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey [see comments]. Jama 1998;280(18):1569-75.
  14. Elkin YN, Makhankov VV, Uvarova NL, Bondarenko PV, Zubarev RA, Knysh AN. Combination of HPLC and 252-Cf plasma desorption mass spectrometry for identifying composition of ginseng tinctures. Chung Kuo Yao Li Hsueh Pao 1993;14(2):97-100.
  15. Enomoto Y, Ito K, Kawagoe Y, Morio Y, Yamasaki Y. Positive inotropic action of saponins on isolated atrial and papillary muscles from the guinea-pig. Br J Pharmacol 1986;88(1):259-67.
  16. Fan ZH, Isobe K, Kiuchi K, Nakashima I. Enhancement of nitric oxide production from activated macrophages by a purified form of ginsenoside (Rg1). Am J Chin Med 1995;23(3-4):279-87.
  17. Hasegawa H, Matsumiya S, Murakami C, Kurokawa T, Kasai R, Ishibashi S, et al. Interactions of ginseng extract, ginseng separated fractions, and some triterpenoid saponins with glucose transporters in sheep erythrocytes. Planta Med 1994;60(2):153-7.
  18. Hong M, Jin Y, Mai YQ, Boersma A, Han KK, Vantyghem MC, et al. The decline of atrial natriuretic peptide (ANP) gene expression in older rats and the effects of ginsenoside on ANP gene expression. Comp Biochem Physiol [b] 1992;101(1-2):35-9.
  19. Huong NT, Matsumoto K, Kasai R, Yamasaki K, Watanabe H. In vitro antioxidant activity of Vietnamese ginseng saponin and its components. Biol Pharm Bull 1998;21(9):978-81.
  20. Iijima M, Higashi T. Effect of ginseng saponins on nuclear ribonucleic acid (RNA) metabolism. II. RNA polymerase activities in rats treated with ginsenoside. Chem Pharm Bull (Tokyo) 1979;27(9):2130-6.
  21. Iishi H, Tatsuta M, Baba M, Uehara H, Nakaizumi A, Shinkai K, et al. Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clin Exp Metastasis 1997;15(6):603-11.
  22. Jiang Y, Zhong GG, Chen L, Ma XY. Influences of ginsenosides Rb1, Rb2, and Rb3 on electric and contractile activities of normal and damaged cultured myocardiocytes. Chung Kuo Yao Li Hsueh Pao 1992;13(5):403-6.
  23. Jin YH, Yoo KJ, Lee YH, Lee SK. Caspase 3-mediated Cleavage of p21{superWAF1/CIP1} Associated with the Cyclin A/Cdk2 Complex is a Prerequisite for Apoptosis in SK-HEP-1 Cells. J Biol Chem 2000.
  24. Kaku T, Kawashima Y. Isolation and characterization of ginsenoside-Rg2, 20R-prosapogenin, 20S-prosapogenin and delta 20-prosapogenin. Chemical studies on saponins of Panax ginseng C. A. Meyer, Third report. Arzneimittelforschung 1980;30(6):936-43.
  25. Kanazawa H, Nagata Y, Matsushima Y, Tomoda M, Takai N. Simultaneous determination of ginsenosides and saikosaponins by high- performance liquid chromatography. J Chromatogr 1990;507(327):327-32.
  26. Kang M, Yoshimatsu H, Oohara A, Kurokawa M, Ogawa R, Sakata T. Ginsenoside Rg1 modulates ingestive behavior and thermal response induced by interleukin-1 beta in rats. Physiol Behav 1995;57(2):393-6.
  27. Kang SY, Lee KY, Lee SK. Ginsenoside-Rg1 regulates the induction of tyrosine aminotransferase gene transcription in rat hepatocyte cultures. Biochem Biophys Res Commun 1994;205(3):1696-701.
  28. Karikura M, Miyase T, Tanizawa H, Takino Y, Taniyama T, Hayashi T. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. V. The decomposition products of ginsenoside Rb2 in the large intestine of rats. Chem Pharm Bull (Tokyo) 1990;38(10):2859-61.
  29. Kenarova B, Neychev H, Hadjiivanova C, Petkov VD. Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Jpn J Pharmacol 1990;54(4):447-54.
  30. Kikuchi Y, Sasa H, Kita T, Hirata J, Tode T, Nagata I. Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo. Anticancer Drugs 1991;2(1):63-7.
  31. Kim HE, Oh JH, Lee SK, Oh YJ. Ginsenoside RH-2 induces apoptotic cell death in rat C6 glioma via a reactive oxygen- and caspase-dependent but Bcl-X(L)-independent pathway. Life Sci 1999;65(3):PL33-40.
  32. Kim HS, Lee JH, Goo YS, Nah SY. Effects of ginsenosides on Ca2+ channels and membrane capacitance in rat adrenal chromaffin cells. Brain Res Bull 1998;46(3):245-51.
  33. Kim MY, Lee KY, Lee SK. Inductive effect of ginsenoside-Rg1 on tyrosine aminotransferase gene expression in rat primary hepatocyte cultures. Biochem Mol Biol Int 1994;34(4):845-51.
  34. Kim ND, Kang SY, Kim MJ, Park JH, Schini KV. The ginsenoside Rg3 evokes endothelium-independent relaxation in rat aortic rings: role of K+ channels. Eur J Pharmacol 1999;367(1):51-7.
  35. Kim ND, Kang SY, Park JH, Schini KV. Ginsenoside Rg3 mediates endothelium-dependent relaxation in response to ginsenosides in rat aorta: role of K+ channels. Eur J Pharmacol 1999;367(1):41-9.
  36. Kim SE, Lee YH, Park JH, Lee SK. Ginsenoside-Rs3, a new diol-type ginseng saponin, selectively elevates protein levels of p53 and p21WAF1 leading to induction of apoptosis in SK-HEP-1 cells. Anticancer Res 1999;19(1A):487-91.
  37. Kim SE, Lee YH, Park JH, Lee SK. Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepatoma SK-HEP-1 cells. Eur J Cancer 1999;35(3):507-11.
  38. Kim YS, Jin SH, Lee YH, Kim SI, Park JD. Ginsenoside Rh2 induces apoptosis independently of Bcl-2, Bcl-xL, or Bax in C6Bu-1 cells. Arch Pharm Res 1999;22(5):448-53.
  39. Kitts D, Hu C. Efficacy and safety of ginseng. Public Health Nutr 2000;3(4A):473-85.
  40. Kitts DD, Wijewickreme AN, Hu C. Antioxidant properties of a North American ginseng extract. Mol Cell Biochem 2000;203(1-2):1-10.
  41. Landes P. Survey indicates increasing herb use. In; 1996: American Botanical Council and Herb Research Foundation; 1996. p. 56.
  42. Lee KY, Lee SK. Ginsenoside-Rg1 positively regulates cyclin E-dependent kinase activity in human hepatoma SK-HEP-1 cells. Biochem Mol Biol Int 1996;39(3):539-46.
  43. Lee KY, Park JA, Chung E, Lee YH, Kim SI, Lee SK. Ginsenoside-Rh2 blocks the cell cycle of SK-HEP-1 cells at the G1/S boundary by selectively inducing the protein expression of p27kip1. Cancer Lett 1996;110(1-2):193-200.
  44. Lee YN, Lee HY, Chung HY, Kim SI, Lee SK, Park BC, et al. In vitro induction of differentiation by ginsenoides in F9 teratocarcinoma cells. Eur J Cancer 1996:1420-8.
  45. Li J, Zhang J. Inhibition of apoptosis by ginsenoside Rg1 in cultured cortical neurons. Chin Med J (Engl) 1997;110(7):535-9.
  46. Liu M, Zhang JT. Effects of ginsenoside Rg1 on c-fos gene expression and cAMP levels in rat hippocampus. Chung Kuo Yao Li Hsueh Pao 1996;17(2):171-4.
  47. Liu SR, Luo ZJ, Yang SX, Yu ML. [Dammarane-type saponins in leaves of Panax collected in Sichuan]. Hua Hsi I Ko Ta Hsueh Hsueh Pao 1989;20(3):331-4.
  48. Liu WK, Xu SX, Che CT. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci 2000;67(11):1297-306.
  49. Liu WK, Xu SX, Che CT. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line [In Process Citation]. Life Sci 2000;67(11):1297-306.
  50. Mindell E. Herb Bible. New York: Fireside Publishers; 1991.
  51. Minyi C. Anticancer Medicinal Herbs. Beijing: Hunan Science and Technology Press; 1992.
  52. Mogil JS, Shin YH, McCleskey EW, Kim SC, Nah SY. Ginsenoside Rf, a trace component of ginseng root, produces antinociception in mice. Brain Res 1998;792(2):218-28.
  53. Moon J, Yu SJ, Kim HS, Sohn J. Induction of G(1) cell cycle arrest and p27(KIP1) increase by panaxydol isolated from Panax ginseng. Biochem Pharmacol 2000;59(9):1109-16.
  54. Nakata H, Kikuchi Y, Tode T, Hirata J, Kita T, Ishii K, et al. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res 1998;89(7):733-40.
  55. Odashima S, Ohta T, Kohno H, Matsuda T, Kitagawa I, Abe H, et al. Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides. Cancer Res 1985;45(6):2781-4.
  56. Oh M, Choi YH, Choi S, Chung H, Kim K, Kim SI, et al. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol 1999;14(5):869-75.
  57. Ong YC, Yong EL. Panax (ginseng)--panacea or placebo? Molecular and cellular basis of its pharmacological activity. Ann Acad Med Singapore 2000;29(1):42-6.
  58. Ota T, Maeda M, Odashima S, Ninomiya TJ, Tatsuka M. G1 phase-specific suppression of the Cdk2 activity by ginsenoside Rh2 in cultured murine cells. Life Sci 1997;60(2):PL39-44.
  59. Oura H, Hiai S, Odaka Y, Yokozawa T. Studies on the biochemical action of ginseng saponin. I. Purification from ginseng extract of the active component stimulating serum protein biosynthesis. J Biochem (Tokyo) 1975;77(5):1057-65.
  60. Pan Z, Ye D, Xie X, Chen H, Lu W. [Antiangiogenesis of ginsenoside Rg3 in severe combined immunodeficient mice with human ovarian carcinoma]. Zhonghua Fu Chan Ke Za Zhi 2002;37(4):227-30.
  61. Park JA, Lee KY, Oh YJ, Kim KW, Lee SK. Activation of caspase-3 protease via a Bcl-2-insensitive pathway during the process of ginsenoside Rh2-induced apoptosis. Cancer Lett 1997;121(1):73-81.
  62. Popovich DG, Kitts DD. Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch Biochem Biophys 2002;406(1):1-8.
  63. Salim KN, McEwen BS, Chao HM. Ginsenoside Rb1 regulates ChAT, NGF and trkA mRNA expression in the rat brain. Brain Res Mol Brain Res 1997;47(1-2):177-82.
  64. Samukawa K, Yamashita H, Matsuda H, Kubo M. [Simultaneous analysis of ginsenosides of various ginseng radix by HPLC]. Yakugaku Zasshi 1995;115(3):241-9.
  65. Sato T, Miyata G. The nutraceutical benefit, part II: ginseng [published erratum appears in Nutrition 2000 Jun;16(6):472]. Nutrition 2000;16(5):391-2.
  66. Shao CJ. [Chemical constituents of flower-buds of Panax ginseng--isolation and identification of ginsenoside-Rb3 and ginsenoside-Rc]. Chung Yao Tung Pao 1984;9(4):172-3.
  67. Shibata S, Ando T, Tanaka O. Chemical studies on the oriental plant drugs. XVII. The prosapogenin of the ginseng saponins (ginsenosides-Rb1, -Rb2, and -Rc). Chem Pharm Bull (Tokyo) 1966;14(10):1157-61.
  68. Shibata S, Ando T, Tanaka O, Meguro Y, Soma K, Iida Y. [Saponins and sapogenins of Panax ginseng C.A. Meyer and some other Panax spp.]. Yakugaku Zasshi 1965;85(8):753-5.
  69. Shibata S, Tanaka O, Ando T, Sado M, Tsushima S, Ohsawa T. Chemical studies on oriental plant drugs. XIV. Protopanaxadiol, a genuine sapogenin of ginseng saponins. Chem Pharm Bull (Tokyo) 1966;14(6):595-600.
  70. Shinkai K, Akedo H, Mukai M, Imamura F, Isoai A, Kobayashi M, et al. Inhibition of in vitro tumor cell invasion by ginsenoside Rg3. Jpn J Cancer Res 1996;87(4):357-62.
  71. Tachikawa E, Kudo K, Kashimoto T, Takahashi E. Ginseng saponins reduce acetylcholine-evoked Na+ influx and catecholamine secretion in bovine adrenal chromaffin cells. J Pharmacol Exp Ther 1995;273(2):629-36.
  72. Takino Y, Odani T, Tanizawa H, Hayashi T. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. I. Quantitative analysis of ginsenoside Rg1 in rats. Chem Pharm Bull (Tokyo) 1982;30(6):2196-201.
  73. Tanaka O, Nagai M, Shibata S. Chemical studies on the oriental plant drugs. XVI. The stereochemistry of protopanaxadiol, a genuine sapogenin of ginseng. Chem Pharm Bull (Tokyo) 1966;14(10):1150-6.
  74. Tao H, Yao M, Zou S, Zhao D, Qiu H. Effect of angiogenesis inhibitor Rg3 on the growth and metastasis of gastric cancer in SCID mice. Zhonghua Wai Ke Za Zhi 2002;40(8):606-8.
  75. Thatte U, Bagadey S, Dahanukar S. Modulation of programmed cell death by medicinal plants. Cell Mol Biol (Noisy-le-grand) 2000;46(1):199-214.
  76. Tong LS, Chao CY. Effects of ginsenoside Rg1 of Panax ginseng on mitosis in human blood lymphocytes in vitro. Am J Chin Med 1980;8(3):254-67.
  77. Verhoef MJ, Sutherland LR. Alternative medicine and general practitioners. Opinions and behaviour. Can Fam Physician 1995;41:1005-11.
  78. Verhoef MJ, Sutherland LR. General practitioners' assessment of and interest in alternative medicine in Canada. Soc Sci Med 1995;41(4):511-5.
  79. Wang X, Sakuma T, Asafu-Adjaye E, Shiu GK. Determination of ginsenosides in plant extracts from Panax ginseng and Panax quinquefolius L. by LC/MS/MS. Anal Chem 1999;71(8):1579-84.
  80. Xia LJ, Han R. [Differentiation of B16 melanoma cells induced by ginsenoside RH2]. Yao Hsueh Hsueh Pao 1996;31(10):742-5.
  81. Yang Z, Xu JD. [Isolation and identification of saponin IV, V, VI and VII in ginseng stems]. Chung Yao Tung Pao 1987;12(8):32-6,63.
  82. Yip TT, Lau CN, But PP, Kong YC. Quantitative analysis of ginsenosides in fresh Panax ginseng. Am J Chin Med 1985;13(1-4):77-88.
  83. Yokozawa T, Yasui T, Oura H. Molecular biological analysis of the effects of ginsenoside-Rb2 on albumin mRNA in streptozotocin-induced diabetic rats. J Pharm Pharmacol 1996;48(7):763-7.
  84. Yoshikawa M, Murakami T, Yashiro K, Yamahara J, Matsuda H, Saijoh R, et al. Bioactive saponins and glycosides. XI. Structures of new dammarane-type triterpene oligoglycosides, quinquenosides I, II, III, IV, and V, from American ginseng, the roots of Panax quinquefolium L. Chem Pharm Bull (Tokyo) 1998;46(4):647-54.
  85. Zhang SL, Chen YJ, Cui CB, He GX, Xu SX, Pei YP, et al. [A new minor saponin from the leaves of Panax ginseng C. A. Meyer]. Yao Hsueh Hsueh Pao 1989;24(11):877-9.
  86. Zhao Y, Yuan C, Lu H. [Isolation and identification of 20(R)-ginsenoside-Rh2 (an anti-cancer constituent) from the fruits of Panax ginseng. C.A. Meyer]. Chung Kuo Chung Yao Tsa Chih 1991;16(11):678-9, 704.
  87. Zhao YQ, Yuan CL. [Chemical constituents of the fruit of Panax ginseng C. A. Meyer]. Chung Kuo Chung Yao Tsa Chih 1993;18(5):296-7, 319